FDA approval was based on results from the largest Phase 3 clinical trial ever conducted for a new treatment against Neisseria gonorrhoeae infection in regions with a high prevalence of gonorrhea ...
A single-dose oral medication called zoliflodacin shows promise as a new treatment for antibiotic-resistant gonorrhea, according to a Phase III trial published in The Lancet. The study found that one ...
Fosfomycin is effective against Gram-positive and Gram-negative bacteria, including drug-resistant strains, and is economically viable for treating uncomplicated UTIs. A meta-analysis of 22 studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results